Work

27900 Maintaining long-term improvements in patient-reported symptoms, signs, and quality of life among patients with moderate to severe plaque psoriasis treated with guselkumab: VOYAGE 2, 5-year data

Year: 2021

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2021.06.680

Authors: April W. Armstrong, Kenneth B. Gordon, Lynda Spelman, Kim A. Papp, Chenglong Han, Michael Song, Yin You, Luis Puig, Laura K. Ferris, Kristian Reich

Institutions: University of Southern California, Medical College of Wisconsin, Probity Medical Research, Veracity Clinical Research, Janssen Research & Development (United States), Universitat Autònoma de Barcelona, Hospital de Sant Pau, University of Pittsburgh, University Medical Center Hamburg-Eppendorf

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3196090700

FWCI:

Cites:

Cited by:

Related to: 10